Scarica l'app Stockscreener
0.6029
22.82%
0.112
Applied Therapeutics Inc Borsa (APLT) Ultime notizie
APLT Shares Results from INSPIRE Trial on Govorestat at Peripheral Nerve Society Meeting | APLT Stock News - GuruFocus
Applied Therapeutics Presents Full 12-Month Clinical Results and - GuruFocus
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewswire
Breakthrough in CMT Treatment: New Clinical Data Shows First-Ever Disease Progression Slowing in 24-Month Study - Stock Titan
Here's Why Amazon Is a Brilliant Buy Now (Hint: It's Not E-Commerce) - The Globe and Mail
Massive News for Apple Stock Investors! - The Globe and Mail
APLT: RBC Capital Reiterates Sector Perform Rating, Price Target Maintained | APLT Stock News - GuruFocus
Applied Therapeutics Reports First Quarter 2025 Financial Results | APLT Stock News - GuruFocus
Applied Therapeutics, Inc. SEC 10-Q Report - TradingView
Barclays PLC Sells 27,997 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
APLT Reports Financial Position and Advances in Govorestat Resea - GuruFocus
Applied Therapeutics Reports First Quarter 2025 Financial Results - Bluefield Daily Telegraph
Applied Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewswire Inc.
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Alyeska Investment Group L.P. Boosts Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class ActionAPLT - ACCESS Newswire
Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT - ACCESS Newswire
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class ActionAPLT - ACCESS Newswire
Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025APLT - ACCESS Newswire
Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire
Applied Therapeutics Announces Acceptance of Late-Breaking Abstr - GuruFocus
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – APLT - ACCESS Newswire
APLT's Govorestat Phase 3 Trial Results to be Presented at 2025 Conference | APLT Stock News - GuruFocus
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewswire
APLT stock touches 52-week low at $0.54 amid market challenges - MSN
Schonfeld Strategic Advisors LLC Acquires 8,419,781 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Applied Therapeutics (APLT) to Release Earnings on Thursday - Defense World
Applied Therapeutics, Inc. (NASDAQ:APLT) Stock Position Increased by Marshall Wace LLP - MarketBeat
Invesco Ltd. Sells 506,118 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Applied Therapeutics (APLT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Adage Capital Partners GP L.L.C. Cuts Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Applied Therapeutics Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Applied Therapeutics, Inc. (NASDAQ:APLT) Holdings Lifted by T. Rowe Price Investment Management Inc. - MarketBeat
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire
Legal & General Group Plc Boosts Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Propel Bio Management LLC Acquires 3,047,562 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Long-Term Investors who hold shares of Applied Therapeutics, - openPR.com
1.54%
7.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):